These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1360888)

  • 41. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas.
    Ehlen T; Dubeau L
    Oncogene; 1990 Feb; 5(2):219-23. PubMed ID: 2320374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
    Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
    Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
    Fong KM; Zimmerman PV; Smith PJ
    Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
    Foulkes WD; Ragoussis J; Stamp GW; Allan GJ; Trowsdale J
    Br J Cancer; 1993 Mar; 67(3):551-9. PubMed ID: 8094976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.
    Kiechle-Schwarz M; Bauknecht T; Wienker T; Walz L; Pfleiderer A
    Cancer; 1993 Oct; 72(8):2423-32. PubMed ID: 8402459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allelic loss on chromosome 17 in human ovarian cancer.
    Phillips N; Ziegler M; Saha B; Xynos F
    Int J Cancer; 1993 Apr; 54(1):85-91. PubMed ID: 8097498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.
    Zborovskaya I; Gasparian A; Karseladze A; Elcheva I; Trofimova E; Driouch K; Trassard M; Tatosyan A; Lidereau R
    Int J Cancer; 1999 Sep; 82(6):822-6. PubMed ID: 10446448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
    Foulkes WD; Black DM; Stamp GW; Solomon E; Trowsdale J
    Int J Cancer; 1993 May; 54(2):220-5. PubMed ID: 8098014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole chromosome 17 loss in ovarian cancer.
    Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F
    Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.
    Shipman R; Schraml P; Colombi M; Raefle G; Ludwig CU
    Hum Genet; 1993 Jun; 91(5):455-8. PubMed ID: 8100210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer.
    Ludwig CU; Raefle G; Dalquen P; Stulz P; Stahel R; Obrecht JP
    Int J Cancer; 1991 Nov; 49(5):661-5. PubMed ID: 1682278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic changes in human adrenocortical carcinomas.
    Yano T; Linehan M; Anglard P; Lerman MI; Daniel LN; Stein CA; Robertson CN; LaRocca R; Zbar B
    J Natl Cancer Inst; 1989 Apr; 81(7):518-23. PubMed ID: 2564050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas.
    Kiechle-Schwarz M; Scherer G; Kovacs G
    Genes Chromosomes Cancer; 1990 Mar; 1(4):312-4. PubMed ID: 1980606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.
    Gabra H; Taylor L; Cohen BB; Lessels A; Eccles DM; Leonard RC; Smyth JF; Steel CM
    Br J Cancer; 1995 Aug; 72(2):367-75. PubMed ID: 7640220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymerase chain reaction allelotyping of human ovarian cancer.
    Osborne RJ; Leech V
    Br J Cancer; 1994 Mar; 69(3):429-38. PubMed ID: 8123469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of Harvey ras heterozygosity in oral squamous carcinoma.
    Howell RE; Wong FS; Fenwick RG
    J Oral Pathol Med; 1989 Feb; 18(2):79-83. PubMed ID: 2568483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.
    Suzuki M; Saito S; Saga Y; Ohwada M; Sato I
    Med Oncol; 1998 Jul; 15(2):119-23. PubMed ID: 9789220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different allelic patterns at chromosome 11q13 in paired aldosterone-producing tumours and blood DNA.
    Gordon R; Gartside M; Tunny T; Stowasser M
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):594-6. PubMed ID: 8800595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.